Platelet Count
Platelets are cell fragments from megakaryocytes that initiate blood clotting at sites of vessel injury. Low counts (thrombocytopenia) raise bleeding risk and can result from immune disorders, liver disease, or marrow failure; high counts (thrombocytosis) occur with inflammation, iron deficiency, or myeloproliferative disease.
Units: thousand/µL; some labs report × 10⁹/L (same number in both units). Check the units on your report before comparing to any range here.
Optimal range: who says what
No institution or named practitioner we track states an optimal target for Platelet Count. How we verify ranges.
- Lab reference interval150-400 thousand/μLWhat a lab report flags against. A lab interval is not an optimal target.
20 of 21 itemized panels
Complete Blood Count (CBC)
What is Platelet Count?
Platelet Count measures the number of platelets (thrombocytes) in your blood. Platelets are small cell fragments produced in bone marrow that play a critical role in blood clotting and wound healing. Normal platelet count is 150,000-400,000 per microliter (μL). Platelets live only 7-10 days, so bone marrow must constantly produce new platelets.
When blood vessels are damaged, platelets rapidly adhere to the injury site, activate, and aggregate to form a platelet plug, initiating the clotting cascade. They also release growth factors that promote tissue repair. Low platelet count (thrombocytopenia) increases bleeding risk, while high count (thrombocytosis) can increase clotting risk, though less predictably than low counts increase bleeding.
Platelet count is one of the most variable blood parameters, fluctuating with inflammation, stress, and certain conditions. Mild elevations (400,000-600,000) are often reactive (secondary thrombocytosis) to infection, inflammation, or iron deficiency and rarely cause problems. Very high counts (>1,000,000) or very low counts (<50,000) require urgent evaluation. Platelet function is as important as count—some people with normal counts have dysfunctional platelets causing bleeding.
Why Platelet Count Is Critical for Clotting and Safety
- Bleeding risk assessment: Platelet <50,000 increases bleeding risk. <20,000 causes spontaneous bleeding requiring urgent treatment
- Surgical safety: Platelet >50,000 generally safe for surgery. <50,000 may require platelet transfusion before procedures
- Medication monitoring: Chemotherapy, immunosuppressants, and some antibiotics can cause life-threatening thrombocytopenia
- Thrombosis risk: Very high platelets (>1,000,000 in myeloproliferative disorders) paradoxically increase both bleeding and clotting
- ITP diagnosis: Isolated low platelets with normal WBC/RBC suggests immune thrombocytopenia requiring specific treatment
- Early cancer detection: Persistent unexplained thrombocytosis may indicate occult malignancy
Interpretation bands (curated, PMID-backed)
Holder: OptimizeBiomarkers editorial synthesis of: Baseline platelet count in percutaneous coronary intervention: a dose-response meta-analysis (Galimzhanov et al., 2022); Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study (Vinholt et al., 2016); Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity (Msaouel et al., 2014). No single paper sets these cutoffs; for attributed targets see who says what.
Optimal180,000-320,000 /μL▼
- Ideal range for hemostasis without increased thrombosis risk
- Provides adequate clotting capacity with minimal risk of either bleeding or thrombotic complications
Borderline130,000-180,000 or 320,000-450,000 /μL▼
- Low-normal may indicate mild ITP, bone marrow suppression, or viral infection
- High-normal often reactive to inflammation, iron deficiency, or recent bleeding
- Monitor with repeat CBC in 4-8 weeks
Thrombocytopenia<150,000 /μL▼
- Low platelets
- Mild (100,000-150,000): Usually asymptomatic, monitor closely
- Moderate (50,000-100,000): Increased bleeding with trauma/surgery, avoid contact sports
- Severe (<50,000): High bleeding risk, may require treatment
- Critical (<20,000): Spontaneous bleeding risk, urgent hospitalization and treatment needed
Thrombocytosis>450,000 /μL▼
- Elevated platelets
- Reactive (450,000-700,000): Usually from infection, inflammation, iron deficiency, bleeding, or splenectomy
- Benign, treat underlying cause
- Primary (>600,000): May indicate myeloproliferative disorder (essential thrombocythemia, polycythemia vera, myelofibrosis)
- Requires JAK2 mutation testing and hematology referral
- Extreme (>1,000,000): High risk bleeding/clotting, urgent treatment
- Baseline platelet count in percutaneous coronary intervention: a dose-response meta-analysis.
- Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study.
- Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity.
What raises or lowers Platelet Count
Causes of high Platelet Count
- Reactive (secondary) thrombocytosis: Infection, inflammation (rheumatoid arthritis, IBD), iron deficiency, acute bleeding, post-splenectomy, malignancy, tissue damage (surgery, trauma)
- Primary thrombocytosis: Essential thrombocythemia (JAK2, CALR, or MPL mutation), Polycythemia vera, Chronic myeloid leukemia, Primary myelofibrosis
- Rebound: Recovery from bone marrow suppression (post-chemotherapy, after treating B12/folate deficiency)
Causes of low Platelet Count
- Decreased production: Bone marrow failure (aplastic anemia), leukemia, myelodysplastic syndrome, chemotherapy, radiation, alcohol, nutritional deficiency (B12, folate)
- Increased destruction: Immune thrombocytopenia (ITP), drug-induced (heparin, quinine, sulfa), autoimmune diseases (SLE), disseminated intravascular coagulation (DIC)
- Splenic sequestration: Enlarged spleen traps platelets (cirrhosis, portal hypertension, lymphoma)
- Dilutional: Massive transfusion of packed RBCs without platelets
- Infections: HIV, hepatitis C, Epstein-Barr virus, sepsis
Symptoms when Platelet Count is high or low
When high
High platelet symptoms:
- Often asymptomatic, especially reactive thrombocytosis
- Headaches, dizziness (if essential thrombocythemia)
- Erythromelalgia: Burning pain in hands/feet, relieved by aspirin
- Visual disturbances: Transient vision changes
- Thrombosis: DVT, PE, stroke, MI (especially if >1,000,000)
- Paradoxical bleeding: Acquired von Willebrand disease with very high counts
Essential thrombocythemia symptoms occur in ~40% of patients. Extreme thrombocytosis (>1,000,000) can cause both bleeding and clotting paradoxically.
When low
Low platelet symptoms:
- Petechiae: Pinpoint red spots on skin (often lower legs)
- Purpura: Larger purple bruises appearing spontaneously
- Easy bruising: Bruises from minor trauma
- Prolonged bleeding: From cuts, nosebleeds that won't stop
- Bleeding gums: Spontaneous or with brushing
- Heavy menstrual bleeding: Menorrhagia
- Blood in urine or stool: Hematuria, GI bleeding
- Severe: Intracranial hemorrhage (if <10,000—medical emergency)
Bleeding risk correlates with platelet count: >50,000 usually asymptomatic, 20,000-50,000 bleeding with trauma, <20,000 spontaneous bleeding risk, <10,000 high risk serious bleeding.
How to move Platelet Count
Effect sizes (how much something moves the marker) appear only where the paper cited under the item states them. Talk to your clinician before starting or changing any medication or supplement.
Treat ITP (Immune Thrombocytopenia)
- Corticosteroids: Prednisone 1 mg/kg daily for 2-4 weeks. Raises platelets in most patients within days to weeks. Taper slowly
- IVIG (Intravenous Immunoglobulin): 1 g/kg for acute severe ITP (<20,000 with bleeding). Rapid platelet increase within 24-48 hours
- Romiplostim or Eltrombopag: TPO receptor agonists stimulate platelet production. For chronic ITP unresponsive to steroids
- Rituximab: Anti-CD20 antibody depletes B-cells. Many ITP patients respond
- Splenectomy: If refractory to medical therapy. Produces lasting remission in many patients but increases infection risk
- Avoid: Aspirin, NSAIDs, other antiplatelet/anticoagulant drugs if platelets <50,000
Manage Thrombocytosis
- Reactive thrombocytosis: Treat underlying cause (infection, inflammation, iron deficiency). Platelets normalize when cause resolves. No specific treatment needed
- Essential thrombocythemia: Low-dose aspirin 81 mg daily reduces thrombosis risk. Hydroxyurea if high risk (age >60, platelets >1,500,000, prior thrombosis)
- Extreme thrombocytosis (>1,000,000): Urgent cytoreduction with hydroxyurea or anagrelide. Platelet pheresis if acute thrombosis
- Avoid unnecessary antiplatelet: Not all thrombocytosis requires aspirin. Risk vs benefit assessment needed
- Iron repletion: If iron deficiency causing reactive thrombocytosis, platelets normalize with iron supplementation
Prevent Drug-Induced Thrombocytopenia
- High-risk medications: Heparin (HIT—heparin-induced thrombocytopenia), quinine, sulfa drugs, vancomycin, linezolid, chemotherapy
- Monitor closely: Check platelet count every 2-3 days when starting heparin. Weekly with chemotherapy
- Discontinue offending drug: If drug-induced thrombocytopenia suspected, stop medication immediately. Platelets recover within 5-10 days in most cases
- HIT management: Stop all heparin immediately. Start direct thrombin inhibitor (argatroban, bivalirudin). HIT causes paradoxical thrombosis despite low platelets
- Chemotherapy support: Platelet transfusion if <10,000 or bleeding. Consider dose reduction or growth factors
Platelet Transfusion Guidelines
- Prophylactic transfusion: If platelets <10,000 to prevent spontaneous bleeding. Each unit raises platelets by ~30,000-50,000
- Pre-procedure transfusion: Transfuse if <50,000 before surgery or invasive procedures. Lower thresholds for low-risk procedures
- Active bleeding: Platelets are transfused during active hemorrhage, to a threshold the treating team sets
- Platelet refractoriness: Some patients don't respond to transfusions due to antibodies. May need HLA-matched platelets
- ITP exception: Avoid transfusion in ITP unless life-threatening bleeding—transfused platelets are rapidly destroyed
Lifestyle and Supportive Care
- If low platelets (<50,000): Avoid contact sports, alcohol (impairs platelet function), NSAIDs/aspirin. Use soft toothbrush. Report any bleeding
- If high platelets (>450,000): Stay hydrated (dehydration increases thrombosis risk), consider aspirin if essential thrombocythemia
- Nutrition: Ensure adequate B12, folate for platelet production. Omega-3 may reduce platelet reactivity (discuss with doctor if on anticoagulants)
- Bleeding precautions: If platelets <20,000, avoid IM injections, rectal temperatures, constipation (straining). Pad sharp corners at home
- Regular monitoring: Check platelets weekly if <50,000, monthly if 50,000-100,000, every 3 months if >450,000
When to retest
- Mild thrombocytopenia (100,000-150,000): Recheck in 4-8 weeks. If stable and asymptomatic, may be chronic mild ITP (benign)
- Moderate to severe (<100,000): Weekly monitoring until stable or rising. Daily if <20,000 until >30,000
- After ITP treatment: Check platelets 2-3 times weekly initially, then weekly, then monthly once stable
- Reactive thrombocytosis: Recheck after treating underlying cause (infection, inflammation). Should normalize in 2-8 weeks
- Essential thrombocythemia: Monitor every 1-3 months against the platelet target your hematologist sets
- Drug-induced: If suspected drug cause, stop medication and recheck in 5-10 days. Should recover if drug-related
- Pre-procedure: Check within 24-48 hours before surgery if history of thrombocytopenia
Scientific Evidence
Bleeding Risk and Platelet Count
In 1,272 patients with low platelets from cancer treatment, prophylactic transfusion at low, medium or high dose when counts were 10,000/µL or lower gave the same rate of grade 2+ bleeding (69-71%). Bleeding occurred on 25% of days with counts of 5,000/µL or lower versus 17% of days at 6,000-80,000/µL.
Source: Dose of prophylactic platelet transfusions and prevention of hemorrhage.
ITP Management Guidelines
The ASH 2019 guideline makes 21 recommendations for immune thrombocytopenia in adults and children, covering observation, corticosteroids, IV immunoglobulin, anti-D, rituximab, splenectomy and thrombopoietin receptor agonists. The panel found little evidence for strong recommendations and favored approaches that avoid medication side effects.
Source: American Society of Hematology 2019 guidelines for immune thrombocytopenia.
Abnormal Platelet Counts and Survival
In 36,262 outpatients aged 65 or older, both thrombocytopenia (HR 1.45) and thrombocytosis (HR 1.75) were associated with shorter survival, and the effect varied by ethnicity.
Which Providers Test Platelet Count?
Cheapest: Oura Health Panels at $99/year. Most comprehensive: Function Health, 160+ biomarkers for $365/year.
20 panels that include it, cheapest first
| Provider | Annual Cost | Total Biomarkers | $/Biomarker |
|---|---|---|---|
| $99 | 50 | $1.98 | |
| $190 | 100+ | $1.90 | |
| $250 | 65 | $3.85 | |
| $297 | 100+ | $2.97 | |
 Labcorp OnDemand | $338 | 50+ | $6.76 |
 Superpower | $349 | 100+ | $3.49 |
| $349 | 75+ | $4.65 | |
 WHOOP Advanced Labs | $349 | 65 | $5.37 |
 Function Health | $365 | 160+ | $2.28 |
| $365 | 100+ | $3.65 | |
| $375 | 108 | $3.47 | |
| $449 | 83 | $5.41 | |
| $495 | 80+ | $6.19 | |
| $499 | 100+ | $4.99 | |
| $700 | 138 | $5.07 | |
| $829 | 54 | $15.35 | |
| $895 | 100+ | $8.95 | |
| $1188 | 70+ | $16.97 | |
| $1198 | 40+ | $29.95 | |
| $1950 | 130+ | $15.00 |
$/Biomarker is annual cost divided by the panel's advertised biomarker count, not the price of this one test. We track 23 blood test providers (32 plans); 21 of those plans are itemized marker by marker. Compare all of them.
1 itemized panel does not include Platelet Count
11 providers not itemized in our matrix
We have not itemized these marker by marker (some sell tests one at a time), so this page cannot say whether they offer Platelet Count. Check with them directly.
Life Extension Standard · Quest Health · Ultrahuman Blood Vision · Lifeforce · Hundred Health · Personalabs · Walk-In Lab · HealthLabs · WHOOP Specialized Panels · Marek Health Essential · Vitality Blueprint Upload
Experts discussing Platelet Count
Podcast episodes where clinicians and researchers cover this marker in depth. Curated by hand; an episode is listed only when the marker is a substantial topic, not a passing mention.
Frequently Asked Questions
What is the optimal range for Platelet Count?
No institution or named practitioner we track states an optimal target for Platelet Count. Lab reference interval: 150-400 thousand/μL. That is what a lab report flags against, not an optimal target.
Which blood test providers include Platelet Count?
20 of the 21 blood testing panels we itemize marker by marker include Platelet Count in their panels. This biomarker is widely available across major providers.
Medical Disclaimer
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.
Last reviewed Sep 23, 2026 · First published Sep 30, 2025